Apollo Care Semaglutide Vials Recalled for Particulate Matter
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Apollo Care, LLC is recalling 250 vials of semaglutide 7.5mg/glycine due to particulate matter contamination.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on August 25, 2026 and geographically references United States. The FDA classifies this as a Class II recall, with the stated reason "Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material", distributed nationwide within the u.s. FDA recall classes run from I (reasonable probability of serious harm) to III (unlikely to cause harm), so the class number is the fastest way to gauge severity here. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
It is tempting to skim, check personal relevance, and move on. The better habit is confirming scope, source, and timestamp first, then reading this alongside related notices instead of drawing a conclusion from one record alone.
The original agency source is linked below so you can verify this record directly before acting on it. Its related labels are recall, product-safety, fda, drugs.
What Happened
Apollo Care, LLC initiated a recall due to the presence of particulate matter identified as nylon/polyamide and silk/proteinaceous-type material.
Which Products Are Affected
SEMAGLUTIDE 7.5mg (5mg/mL), Glycine 7.5 mg (5mg/mL), 1.5 mL Sterile Multi-Dose Vial, Rx Only, For Subcutaneous Injection Only, APOLLO care, NDC 71170-721-01. Lot: AC-017273, Exp. 12/12/2026. Quantity: 250 vials. Distributed nationwide within the U.S.
What You Should Do
Consumers should not use the affected product and contact the recalling firm for further instructions.
Why This Matters
This Class II recall involves a drug product distributed nationwide.
Source
FDA recall number D-0755-2026
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Getinge PVC Thoracic Catheters Recall Over Bacterial Endotoxin Testing (Aug 7, 2026)
FDA · September 22, 2026
C.R. Bard Foley Catheter Trays Recall Over Pericare Wipes Contamination (Jun 25, 2026)
FDA · September 22, 2026
Given Imaging Bravo CF Capsule Delivery Device Recall Over Detachment Risk
FDA · September 22, 2026
Similar notices nationwide by length or severity timing 8
Two cross-category peer sets, both computed from Areazine's own archive: notices with a similar body length, and notices near the same severity and agency date. These are drawn from other categories, not the same-feed Related list above.
Similar body length
Nearest notices by article body length (712 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to August 25, 2026.
Common Questions
What people usually ask about a notice like this one.